Dr. Hoentjen’s research focuses on optimizing therapies, standardizing care, and understanding the risk of colorectal cancer and dysplasia for people with IBD.
Dr. Peerani’s research investigates the pathophysiology and management of elderly-onset IBD as well as the presentation of IBD in patients with primary sclerosing cholangitis.
To learn more about Dr. Peerani’s clinical and research interests, click here: PubMed | University of Alberta
Dr. Karen Wong, MD, FRCPC
Dr. Wong’s research focuses on exploring fecal microbiota transplants, optimizing treatments, and improving the quality of life for patients with IBD, particularly through the optimization of digital health tools.